rs113299143
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001371623.1(TCOF1):c.1281G>A(p.Ala427=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00351 in 1,612,508 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001371623.1 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCOF1 | NM_001371623.1 | c.1281G>A | p.Ala427= | splice_region_variant, synonymous_variant | 10/27 | ENST00000643257.2 | NP_001358552.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCOF1 | ENST00000643257.2 | c.1281G>A | p.Ala427= | splice_region_variant, synonymous_variant | 10/27 | NM_001371623.1 | ENSP00000493815 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00284 AC: 427AN: 150582Hom.: 2 Cov.: 34
GnomAD3 exomes AF: 0.00279 AC: 695AN: 248804Hom.: 4 AF XY: 0.00277 AC XY: 375AN XY: 135172
GnomAD4 exome AF: 0.00358 AC: 5226AN: 1461816Hom.: 23 Cov.: 34 AF XY: 0.00341 AC XY: 2482AN XY: 727206
GnomAD4 genome AF: 0.00283 AC: 427AN: 150692Hom.: 2 Cov.: 34 AF XY: 0.00251 AC XY: 185AN XY: 73578
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 04, 2020 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | TCOF1: BP4, BP7, BS1, BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Treacher Collins syndrome 1 Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Likely benign, no assertion criteria provided | not provided | Genetics Laboratories, Oxford Radcliffe Hospitals NHS Trust | - | - - |
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 28, 2021 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 25, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 10, 2015 | - - |
TCOF1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 06, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at